Tapewire

Nasdaq · USD

PALI

PALISADE BIO, INC.

Export transactions ↓
Tapewire entity
5803
SEC CIK
0001357459
Parsed reports
182

Last 12 months

Inside the activity.

10 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202620
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202662
Aug 202600
Sep 202600
Oct 202620

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 11, 2023 Filed Jun 13, 2023 18:44 UTC GrantRestricted Stock Units · Derivative 6,980 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-021126 · ownership.xml · derivative · entry 1

Diaz Stephanie · CIK 0001850265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,980

Underlying: Common Stock · 6,980 shares

Expires not disclosed

F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.

F3 · security: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · shares: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

F4 · derivative.expiration_date: N/A

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC
Wei BinxianDirector
GrantCommon Stock Options · Derivative 9,580 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001493152-23-021127 · ownership.xml · derivative · entry 2

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,580

Underlying: Common Stock · 9,580 shares

Expires 2033-06-11

F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F5 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC
Wei BinxianDirector
GrantRestricted Stock Units · Derivative 6,980 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-021127 · ownership.xml · derivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,980

Underlying: Common Stock · 6,980 shares

Expires not disclosed

F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.

F3 · security: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · shares: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

F4 · derivative.expiration_date: N/A

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC GrantCommon Stock Options · Derivative 9,580 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001493152-23-021128 · ownership.xml · derivative · entry 2

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,580

Underlying: Common Stock · 9,580 shares

Expires 2033-06-11

F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F5 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC GrantRestricted Stock Units · Derivative 6,980 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-021128 · ownership.xml · derivative · entry 1

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,980

Underlying: Common Stock · 6,980 shares

Expires not disclosed

F1 · security: Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.

F3 · security: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · shares: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

F4 · derivative.expiration_date: N/A

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC GrantCommon Stock Options · Derivative 12,160 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001493152-23-021132 · ownership.xml · derivative · entry 2

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,160

Underlying: Common Stock · 12,160 shares

Expires 2033-06-11

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F5 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC GrantRestricted Stock Units · Derivative 5,100 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-021132 · ownership.xml · derivative · entry 1

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,100

Underlying: Common Stock · 5,100 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant.

F3 · security: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · shares: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

F4 · derivative.expiration_date: N/A

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC
Neal James RDirector
GrantCommon Stock Options · Derivative 12,160 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001493152-23-021130 · ownership.xml · derivative · entry 2

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,160

Underlying: Common Stock · 12,160 shares

Expires 2033-06-11

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F5 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:44 UTC
Neal James RDirector
GrantRestricted Stock Units · Derivative 5,100 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-021130 · ownership.xml · derivative · entry 1

Neal James R · CIK 0001600865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,100

Underlying: Common Stock · 5,100 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant.

F3 · security: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · shares: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

F4 · derivative.expiration_date: N/A

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:43 UTC GrantCommon Stock Options · Derivative 12,160 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001493152-23-021129 · ownership.xml · derivative · entry 2

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,160

Underlying: Common Stock · 12,160 shares

Expires 2033-06-11

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant.

F2 · security: The grants vest fully on the one (1) year anniversary of the grant date.

F5 · security: Each option represents the right to purchase one share of common stock at the exercise price.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

Read SEC document
June 11, 2023 Filed Jun 13, 2023 22:43 UTC GrantRestricted Stock Units · Derivative 5,100 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-021129 · ownership.xml · derivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,100

Underlying: Common Stock · 5,100 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant.

F3 · security: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_price: The grants vest fully on the one (1) year anniversary of the grant date.

F3 · shares: Each restricted stock unit represents the right to receive one share of common stock.

F2 · derivative.exercise_date: The grants vest fully on the one (1) year anniversary of the grant date.

F4 · derivative.expiration_date: N/A

Read SEC document
April 03, 2023 Filed Apr 5, 2023 18:52 UTC
McRae Robert CurtisChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 655 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-23-011082 · ownership.xml · derivative · entry 3

McRae Robert Curtis · CIK 0001965845 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,963

Underlying: Common Stock · 655 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F3 · derivative.exercise_date: This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F3 · derivative.expiration_date: This restricted stock unit was granted on January 3, 2023, and 655 restricted stock units subject to the award vested on April 3, 2023, and approximately 654 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 18:52 UTC
McRae Robert CurtisChief Operating Officer
Tax withholdingCommon Stock, par value $0.01 270 $2.00 $540.00
Disclosure

SEC source: 0001493152-23-011082 · ownership.xml · nonDerivative · entry 2

McRae Robert Curtis · CIK 0001965845 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 625

F2 · security: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

F2 · price: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 18:52 UTC
McRae Robert CurtisChief Operating Officer
Exercise / conversionCommon Stock, par value $0.01 655 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-011082 · ownership.xml · nonDerivative · entry 1

McRae Robert Curtis · CIK 0001965845 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 22:49 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionRestricted Stock Units · Derivative 1,309 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-23-011080 · ownership.xml · derivative · entry 4

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,927

Underlying: Common Stock · 1,309 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F4 · derivative.exercise_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on April 3, 2023, and 1,309 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

F4 · derivative.expiration_date: This restricted stock unit was granted on January 3, 2023, and 1,309 restricted stock units subject to the award vested on April 3, 2023, and 1,309 restricted stock units are scheduled to vest on each of July 3, 2023, October 3, 2023, and January 3, 2023, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 22:49 UTC
Finley John DavidDirector · CEO, CFO, Director
Tax withholdingCommon Stock, par value $0.01 435 $2.01 $874.35
Disclosure

SEC source: 0001493152-23-011080 · ownership.xml · nonDerivative · entry 2

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,848

F2 · security: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

F2 · price: Represents shares withheld by Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 22:49 UTC
Finley John DavidDirector · CEO, CFO, Director
Exercise / conversionCommon Stock, par value $0.01 1,309 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-011080 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,283

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

F1 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.

Read SEC document
February 06, 2023 Filed Feb 9, 2023 02:01 UTC
Finley John DavidDirector · CEO, CFO, Director
GrantCommon Stock Purchase Option · Derivative 57,200 $0.00 Strike: $2.40 $0.00
Disclosure

SEC source: 0001493152-23-003989 · ownership.xml · derivative · entry 3

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,200

Underlying: Common Stock · 57,200 shares

Expires 2033-02-06

F1 · security: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F2 · security: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25

F1 · shares: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F2 · shares: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25

F1 · derivative.exercise_date: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F2 · derivative.exercise_date: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25

Read SEC document
February 06, 2023 Filed Feb 9, 2023 02:01 UTC
Finley John DavidDirector · CEO, CFO, Director
GrantRestricted Performance Stock Units · Derivative 32,500 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-003989 · ownership.xml · derivative · entry 2

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 32,500 shares

Expires 2033-02-06

F1 · security: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F2 · security: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25

F3 · derivative.exercise_price: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F3 · shares: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F2 · derivative.exercise_date: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25

Read SEC document
February 06, 2023 Filed Feb 9, 2023 02:01 UTC
Finley John DavidDirector · CEO, CFO, Director
GrantRestricted Stock Units · Derivative 41,700 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-003989 · ownership.xml · derivative · entry 1

Finley John David · CIK 0001851034 · Director · CEO, CFO, Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,700

Underlying: Common Stock · 41,700 shares

Expires not disclosed

F1 · security: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F2 · security: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25

F3 · derivative.exercise_price: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F3 · shares: Each RSU or PSU represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Each grant represents a one-time bonus grant to Reporting Person for services as an executive officer for the year ended December 31, 2022. The grants were issued from the Issuer's 2021 Equity Incentive Plan. Vesting for each grant is subject to: (a) the Reporting Person being a service provider to the Issuer at the time of vesting and (b) shareholder approval of the applicable grant is received.

F2 · derivative.exercise_date: The applicable grant will vest: with respect to the Restricted Stock Units ("RSUs") and Common Stock Purchase Options ("Options"), in twelve (12) equal quarterly installments over a three-year period from the grant date, and with respect to the Performance Restricted Stock Units ("PSUs"), (i) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $3.20, and (ii) 50% at such time when the volume weighted average price of the Company's common stock over a twenty (20) consecutive trading day period is at or greater than $4.25

F4 · derivative.expiration_date: N/A

Read SEC document
January 03, 2023 Filed Jan 7, 2023 00:42 UTC
Finley John DavidChief Executive Officer
GrantRestricted Stock Units · Derivative 5,236 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-000862 · ownership.xml · derivative · entry 1

Finley John David · CIK 0001851034 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,236

Underlying: Common Stock · 5,236 shares

Expires not disclosed

F1 · security: Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan.

F1 · shares: Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan.

F1 · derivative.exercise_date: Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24.

F3 · derivative.expiration_date: N/A

Read SEC document
September 01, 2022 Filed Sep 2, 2022 22:21 UTC
Finley John DavidChief Financial Officer
PurchaseCommon Stock, par value $0.01 19,481.242 $0.14 $2,799.45
Disclosure

SEC source: 0001493152-22-025023 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,727.242

F1 · price: Reporting Person purchased 19,481.242 shares of Common Stock of Issuer at prices ranging from $0.1437 to $0.1439 with a weighted average price per share of $0.1437 on September 1 2022. The reporting person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC staff, the Issuer, or a security holder of the Issuer

Read SEC document
August 23, 2022 Filed Aug 25, 2022 21:10 UTC
Finley John DavidChief Financial Officer
PurchaseCommon Stock, par value $0.01 7,350 $0.16 $1,176.00
Disclosure

SEC source: 0001493152-22-024082 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,246

F1 · kind: Reporting Person purchased 7,350 shares of Common Stock of Issuer at a price per share of $0.16 on August 23, 2022.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:06 UTC
Hallam ThomasDirector · Chief Executive Officer
PurchaseSeries 2 Common Stock Purchase Warrant · Derivative 40,000 $0.00 Strike: $0.25 $0.00
Disclosure

SEC source: 0001493152-22-023511 · ownership.xml · derivative · entry 3

Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2027-08-16

F3 · kind: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

F3 · derivative.exercise_date: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:06 UTC
Hallam ThomasDirector · Chief Executive Officer
PurchaseSeries 1 Common Stock Purchase Warrant · Derivative 40,000 $0.00 Strike: $0.25 $0.00
Disclosure

SEC source: 0001493152-22-023511 · ownership.xml · derivative · entry 2

Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2023-08-16

F2 · kind: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

F2 · derivative.exercise_date: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

Read SEC document
August 16, 2022 Filed Aug 18, 2022 21:06 UTC
Hallam ThomasDirector · Chief Executive Officer
PurchaseCommon Stock, par value $0.01 40,000 $0.25 $10,000.00
Disclosure

SEC source: 0001493152-22-023511 · ownership.xml · nonDerivative · entry 1

Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,592

F1 · kind: Represents common shares underlying 40,000 Units of Issuer purchased by Reporting Person ("Units") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25.

Read SEC document
August 16, 2022 Filed Aug 19, 2022 01:04 UTC
Finley John DavidChief Financial Officer
PurchaseSeries 2 Common Stock Purchase Warrant · Derivative 100,000 $0.00 Strike: $0.25 $0.00
Disclosure

SEC source: 0001493152-22-023510 · ownership.xml · derivative · entry 4

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-08-16

F4 · kind: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

F4 · derivative.exercise_date: Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

Read SEC document
August 16, 2022 Filed Aug 19, 2022 01:04 UTC
Finley John DavidChief Financial Officer
PurchaseSeries 1 Common Stock Purchase Warrant · Derivative 100,000 $0.00 Strike: $0.25 $0.00
Disclosure

SEC source: 0001493152-22-023510 · ownership.xml · derivative · entry 3

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2023-08-16

F3 · kind: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

F3 · derivative.exercise_date: Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.

Read SEC document
August 16, 2022 Filed Aug 19, 2022 01:04 UTC
Finley John DavidChief Financial Officer
PurchaseCommon Stock, par value $0.01 100,000 $0.25 $25,000.00
Disclosure

SEC source: 0001493152-22-023510 · ownership.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,896

F1 · kind: Represents common shares underlying 100,000 Units of Issuer purchased by Reporting Person ("Units") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25.

Read SEC document
April 29, 2022 Filed May 2, 2022 21:34 UTC
Finley John DavidChief Financial Officer
OtherCommon Stock 12,545 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-026450 · doc4.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By FCW Investments LLC

Disclosed balance after: 38,867

F1 · kind: Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution.

F1 · price: Represents a distribution of partnership assets (shares of Palisade Bio, Inc. common stock) made by LBS Investors LP to its partners in connection with the partnership's dissolution. No additional payment is being made by any of the partners in connection with the distribution.

F2 · ownership.nature: The Reporting Person is the managing member of FCW Investments LLC and has sole investment and voting power over the securities held by this entity.

Read SEC document
March 29, 2022 Filed Mar 31, 2022 12:31 UTC
Dawson Michael JohnChief Medical Officer
PurchaseCommon Stock 15,000 $1.14 $17,092.50
Disclosure

SEC source: 0001209191-22-021681 · doc4.xml · nonDerivative · entry 1

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
March 28, 2022 Filed Mar 29, 2022 08:37 UTC
Hallam ThomasDirector · Chief Executive Officer
PurchaseCommon Stock 10,000 $1.18 $11,800.00
Disclosure

SEC source: 0001209191-22-021405 · doc4.xml · nonDerivative · entry 1

Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,592

Read SEC document
March 24, 2022 Filed Mar 25, 2022 12:01 UTC
Finley John DavidChief Financial Officer
PurchaseCommon Stock 7,500 $1.09 $8,174.25
Disclosure

SEC source: 0001209191-22-021051 · doc4.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,896

Read SEC document
February 17, 2022 Filed Feb 22, 2022 17:58 UTC
Hallam ThomasDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 156,600 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001209191-22-011856 · doc4.xml · derivative · entry 1

Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,600

Underlying: Common Stock · 156,600 shares

Expires 2032-02-16

F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 22:57 UTC
Finley John DavidChief Financial Officer
GrantStock Option (right to buy) · Derivative 64,800 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001209191-22-011855 · doc4.xml · derivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,800

Underlying: Common Stock · 64,800 shares

Expires 2032-02-16

F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 22:54 UTC
Dawson Michael JohnChief Medical Officer
GrantStock Option (right to buy) · Derivative 32,400 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001209191-22-011853 · doc4.xml · derivative · entry 1

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,400

Underlying: Common Stock · 32,400 shares

Expires 2032-02-16

F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 18:26 UTC GrantStock Option (right to buy) · Derivative 48,340 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008586 · doc4.xml · derivative · entry 1

Trenschel Robert J. · CIK 0001849917 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-11-17

F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 18:36 UTC
Hallam ThomasDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 267,868 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008592 · doc4.xml · derivative · entry 1

Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,868

Underlying: Common Stock · 267,868 shares

Expires 2031-11-17

F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 23:39 UTC
Finley John DavidChief Financial Officer
GrantStock Option (right to buy) · Derivative 178,091 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008594 · doc4.xml · derivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 178,091

Underlying: Common Stock · 178,091 shares

Expires 2031-11-17

F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 18:16 UTC GrantStock Option (right to buy) · Derivative 48,340 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008571 · doc4.xml · derivative · entry 1

Diaz Stephanie · CIK 0001850265 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-11-17

F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 23:40 UTC
Dawson Michael JohnChief Medical Officer
GrantStock Option (right to buy) · Derivative 39,294 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008596 · doc4.xml · derivative · entry 1

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,294

Underlying: Common Stock · 39,294 shares

Expires 2031-11-17

F1 · derivative.exercise_date: 1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 23:23 UTC GrantStock Option (right to buy) · Derivative 48,340 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008581 · doc4.xml · derivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-11-17

F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 23:19 UTC
Neal James RDirector
GrantStock Option (right to buy) · Derivative 48,340 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008575 · doc4.xml · derivative · entry 1

Neal James R · CIK 0001600865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-11-17

F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 23:11 UTC
Wei BinxianDirector
GrantStock Option (right to buy) · Derivative 48,340 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008569 · doc4.xml · derivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-11-17

F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 23:02 UTC GrantStock Option (right to buy) · Derivative 48,340 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008562 · doc4.xml · derivative · entry 1

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-11-17

F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.

Read SEC document
November 18, 2021 Filed Feb 10, 2022 23:07 UTC GrantStock Option (right to buy) · Derivative 48,340 $0.00 Strike: $2.32 $0.00
Disclosure

SEC source: 0001209191-22-008565 · doc4.xml · derivative · entry 1

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,340

Underlying: Common Stock · 48,340 shares

Expires 2032-11-17

F1 · derivative.exercise_date: 25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period.

Read SEC document
September 21, 2021 Filed Sep 22, 2021 19:35 UTC
Hallam ThomasDirector · Chief Executive Officer
PurchaseCommon Stock 6,000 $2.49 $14,940.00
Disclosure

SEC source: 0001209191-21-057318 · doc4.xml · nonDerivative · entry 1

Hallam Thomas · CIK 0001850921 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,592

Read SEC document
September 21, 2021 Filed Sep 22, 2021 23:36 UTC
Finley John DavidChief Financial Officer
PurchaseCommon Stock 2,000 $2.44 $4,880.00
Disclosure

SEC source: 0001209191-21-057319 · doc4.xml · nonDerivative · entry 1

Finley John David · CIK 0001851034 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,396

Read SEC document
September 10, 2021 Filed Sep 13, 2021 18:40 UTC PurchaseCommon Stock 2,142 $2.98 $6,383.16
Disclosure

SEC source: 0001209191-21-055729 · doc4.xml · nonDerivative · entry 5

Trenschel Robert J. · CIK 0001849917 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,999

Read SEC document
September 09, 2021 Filed Sep 13, 2021 18:40 UTC PurchaseCommon Stock 3,400 $2.89 $9,826.00
Disclosure

SEC source: 0001209191-21-055729 · doc4.xml · nonDerivative · entry 4

Trenschel Robert J. · CIK 0001849917 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,857

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.